Genipin and EDC crosslinking of extracellular matrix hydrogel derived from human umbilical cord for neural tissue repair
Published 2019 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genipin and EDC crosslinking of extracellular matrix hydrogel derived from human umbilical cord for neural tissue repair
Authors
Keywords
-
Journal
Scientific Reports
Volume 9, Issue 1, Pages -
Publisher
Springer Science and Business Media LLC
Online
2019-07-23
DOI
10.1038/s41598-019-47059-x
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Extracellular matrix hydrogel therapies: In vivo applications and development
- (2018) Martin T. Spang et al. Acta Biomaterialia
- The Effect of Human Mesenchymal Stem Cells Derived from Wharton’s Jelly in Spinal Cord Injury Treatment Is Dose-Dependent and Can Be Facilitated by Repeated Application
- (2018) Petr Krupa et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Injectable hydroxyphenyl derivative of hyaluronic acid hydrogel modified with RGD as scaffold for spinal cord injury repair
- (2018) Kristyna Zaviskova et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
- Assessment of the characteristics and biocompatibility of gelatin sponge scaffolds prepared by various crosslinking methods
- (2018) Gang Yang et al. Scientific Reports
- Extracellular matrix based biomaterials for central nervous system tissue repair: the benefits and drawbacks
- (2017) Sarka Kubinova Neural Regeneration Research
- Extracellular Matrix Hydrogel Derived from Human Umbilical Cord as a Scaffold for Neural Tissue Repair and Its Comparison with Extracellular Matrix from Porcine Tissues
- (2017) Zuzana Kočí et al. TISSUE ENGINEERING PART C-METHODS
- ECM hydrogel for the treatment of stroke: Characterization of the host cell infiltrate
- (2016) Harmanvir Ghuman et al. BIOMATERIALS
- Therapeutic Potential of Genipin in Central Neurodegenerative Diseases
- (2016) Yanwei Li et al. CNS DRUGS
- Injectable Extracellular Matrix Hydrogels as Scaffolds for Spinal Cord Injury Repair
- (2016) Dmitry Tukmachev et al. TISSUE ENGINEERING PART A
- Modulating in vivo degradation rate of injectable extracellular matrix hydrogels
- (2016) Jean W. Wassenaar et al. Journal of Materials Chemistry B
- Genipin crosslinking reduced the immunogenicity of xenogeneic decellularized porcine whole-liver matrices through regulation of immune cell proliferation and polarization
- (2016) Yujia Wang et al. Scientific Reports
- To Cross-Link or Not to Cross-Link? Cross-Linking Associated Foreign Body Response of Collagen-Based Devices
- (2015) Luis M. Delgado et al. TISSUE ENGINEERING PART B-REVIEWS
- Astrocyte infiltration into injectable collagen-based hydrogels containing FGF-2 to treat spinal cord injury
- (2013) Daniel J. Macaya et al. BIOMATERIALS
- Preparation and characterization of genipin-crosslinked rat acellular spinal cord scaffolds
- (2013) Tao Jiang et al. Materials Science & Engineering C-Materials for Biological Applications
- Conditionally immortalized stem cell lines from human spinal cord retain regional identity and generate functional V2a interneurons and motorneurons
- (2013) Graham Cocks et al. Stem Cell Research & Therapy
- Biologic scaffolds composed of central nervous system extracellular matrix
- (2012) Peter M. Crapo et al. BIOMATERIALS
- Hydrogels derived from central nervous system extracellular matrix
- (2012) Christopher J. Medberry et al. BIOMATERIALS
- Biomaterials combined with cell therapy for treatment of spinal cord injury
- (2012) Šárka Kubinová et al. Regenerative Medicine
- Injectable Collagen-Genipin Gel for the Treatment of Spinal Cord Injury: In Vitro Studies
- (2011) Daniel Macaya et al. ADVANCED FUNCTIONAL MATERIALS
- Genipin-cross-linked collagen/chitosan biomimetic scaffolds for articular cartilage tissue engineering applications
- (2010) Le-Ping Yan et al. JOURNAL OF BIOMEDICAL MATERIALS RESEARCH PART A
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started